Advisory Resource Group Has $5.15 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Advisory Resource Group increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2,136.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,840 shares of the healthcare conglomerate's stock after acquiring an additional 9,400 shares during the period. UnitedHealth Group comprises about 1.0% of Advisory Resource Group's portfolio, making the stock its 27th largest position. Advisory Resource Group's holdings in UnitedHealth Group were worth $5,154,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in UNH. Norges Bank bought a new position in UnitedHealth Group in the fourth quarter valued at $6,375,744,000. GAMMA Investing LLC grew its position in UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at $1,914,740,000. Amundi grew its position in UnitedHealth Group by 97.2% in the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after acquiring an additional 2,301,010 shares during the period. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on UNH shares. Bank of America downgraded shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and decreased their price objective for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. JPMorgan Chase & Co. decreased their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research report on Thursday, May 15th. KeyCorp reduced their target price on shares of UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating for the company in a report on Monday, June 2nd. Finally, Piper Sandler decreased their price target on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 3rd. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $426.52.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director John H. Noseworthy purchased 300 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the purchase, the director now owns 6,063 shares of the company's stock, valued at $1,892,626.08. This represents a 5.21% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the company's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $306.90 on Thursday. The company has a 50 day moving average of $370.86 and a 200-day moving average of $467.96. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The company has a market cap of $278.40 billion, a PE ratio of 12.85, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the company posted $6.91 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a yield of 2.88%. UnitedHealth Group's payout ratio is presently 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.